Health

  • April 28, 2026

    Nurses Fight 'Deceptive' Opt-Out Push In $14M Wage Deal

    Nurses involved in a $14 million wage-and-hour class settlement are urging a Colorado federal judge to block what they call a misleading opt-out campaign by a named plaintiff in a related action in state court, saying mass texts promising unsubstantiated recoveries threaten to undermine the deal.

  • April 28, 2026

    Maryland Justices Allow IVF Cost Class Action To Proceed

    A Maryland couple can pursue a proposed class action against a health insurer that they say wrongfully denied coverage for embryo thawing in connection with an in vitro fertilization procedure, the Maryland Supreme Court has ruled, finding that the insurer's subsequent payment of the claim doesn't moot the suit.

  • April 28, 2026

    Ga. Parents Say Child's $37M Death Verdict Wrongly Reduced

    A couple whose son died during lymphoma treatment at a university medical center told a Georgia appellate panel Tuesday that a trial court misinterpreted the state's tort claims act when it reduced a verdict in their favor from $37 million to $2 million.

  • April 28, 2026

    Eli Lilly Inks $2.25B AI Genetics Research Pact With Profluent

    AI-focused biotech Profluent said Tuesday it has entered a multiprogram, strategic research collaboration with Eli Lilly and Co. to treat diseases with high unmet need, in a deal that involves an upfront payment and up to $2.25 billion in additional milestone payments. 

  • April 28, 2026

    Meet The Attys Arguing The High Court 'Skinny Label' Case

    When the U.S. Supreme Court hears arguments Wednesday in a patent case involving "skinny labels" on generic drugs, a longtime patent attorney as well as a government attorney who often handles intellectual property cases will face an appellate specialist who has argued many high court cases.

  • April 28, 2026

    Anti-Pot Group Says CMS Violated APA With Hemp Program

    A group of advocates opposed to legal cannabis, as well as a cannabinoid company and two individuals, are fighting the government's bid to halt their challenge to a program to give Medicare beneficiaries access to federally legal hemp products, saying the Centers for Medicare & Medicaid Services violated federal law by instituting the program without notice or comment.

  • April 27, 2026

    North Dakota Drug-Pricing Law Blocked In Pharma Fight

    A North Dakota federal judge on Monday blocked the state's new drug-pricing law, agreeing with pharmaceutical companies that while the law purports to "protect the underdogs," it illegally interferes with the federal drug-pricing regime.

  • April 27, 2026

    DOJ Says Wash. 340B Drug Law Is Preempted In Novartis Suit

    The U.S. Department of Justice waded into a dispute between pharmaceutical giants and the state of Washington on Monday, arguing that federal law preempts a new state law that expands discounts that drugmakers must provide under the federal 340B Drug Pricing Program.

  • April 27, 2026

    Sullivan & Cromwell Alum Returns After 5 Years With DOJ

    A former Sullivan & Cromwell attorney is returning to the firm after five years in the public sector working for the U.S. Department of Justice's criminal division, where he prosecuted high-profile insider trading cases and secured convictions for two former Merrill Lynch traders accused of manipulating the precious metals market.

  • April 27, 2026

    Wyoming's Latest Near-Total Abortion Ban Blocked

    A Wyoming judge has blocked enforcement of the latest effort by state lawmakers to enact a rigid anti-abortion law, after the Wyoming Supreme Court in January struck down the state's previous near-total ban on abortion. 

  • April 27, 2026

    'General Hospital' Actor Can't Revive Vax Suit Against ABC

    California appellate justices refused to reinstate a "General Hospital" actor's suit alleging ABC fired him for his political views after he declined to comply with its COVID-19 vaccine policy, ruling the evidence shows that the ultimate decision-makers who ended his employment agreement didn't know about his political views.

  • April 27, 2026

    ER Docs Urge Justices To Back 5th Circ. Revival Of BCBS Suit

    Emergency room doctors urged the U.S. Supreme Court on Monday not to disturb a Fifth Circuit decision reviving their insurance reimbursement dispute against Blue Cross Blue Shield involving out-of-network claims from employee benefit plans, arguing the appellate court correctly restarted proceedings in the case.

  • April 27, 2026

    Nursing Home Hit With Wage Suit Over Meal, OT Pay

    Two former caregivers have hit a Michigan assisted living and memory care facility with a proposed collective action, alleging the facility failed to properly pay overtime by requiring hourly employees to work through unpaid meal breaks and excluding bonuses from overtime calculations. 

  • April 27, 2026

    Attys, Advocates Call DOJ Pot Rule Historic Shift For Feds

    Legal strategies are evolving quickly in the wake of last week's "historic" rescheduling of state-legal medical cannabis, as a group of attorneys and advocates gathered Monday to evaluate the trade-offs of dispensaries now being able to register like pharmacies with the feds and the potential effect on industry investments and trade.

  • April 27, 2026

    IQVIA Accuses Ex-Execs, Syneos Of Poaching $180M Client

    IQVIA Holdings Inc. is accusing former executives of defecting to a competitor in the clinical research organization industry and initiating a corporate raid that resulted in the loss of one customer worth at least $180 million, according to a lawsuit filed in North Carolina Business Court.

  • April 27, 2026

    4 Firms Build Astorg's $1.1B Microbiology Biz Buy

    Life sciences company Thermo Fisher Scientific Inc. on Monday announced plans to sell its microbiology business to European private equity firm Astorg in an over $1.1 billion deal steered by four law firms.

  • April 27, 2026

    Ex-Federal Workers Seek Reinstatement In Md. Federal Court

    The Trump administration disguised ideologically motivated firings as routine layoffs, then pushed workers into a broken system to challenge their discharges, a group of laid-off federal workers alleged, asking a Maryland federal judge to deem the layoffs unconstitutional and reinstate the workers to their former positions.

  • April 27, 2026

    Cannabis Co. Can't Shift Atty AI Sanctions To Rival Company

    A Florida federal judge will not force a medical marijuana company to accept liability for sanctions incurred by its in-house counsel over the misuse of generative artificial intelligence, rejecting a rival company's arguments that the lawyer previously avoided monetary sanctions for filing errors and was likely to do so again.

  • April 27, 2026

    Convicted Pa. Dentist Says Feds Failed To Prove Fraud

    A Pennsylvania dentist convicted along with his brother for using their dental practice to defraud Medicare, install unapproved dental implants in patients, and falsify visas to recruit foreign workers has asked a federal judge for acquittal or a new trial, arguing the government failed to show he committed any crimes.

  • April 27, 2026

    Medical Group Says Secret Call Could Upend Estate's Verdict

    A Connecticut anesthesiology group has asked a state appeals court to reverse its portion of a $20 million wrongful death verdict, saying a lower court judge should have allowed into evidence a secret phone recording of a surgeon, used different verdict forms and blocked testimony from an allegedly unqualified witness.

  • April 27, 2026

    What To Watch As Justices Take On 'Skinny Label' Case

    The U.S. Supreme Court will hear arguments Wednesday on whether to permit a patent suit over a generic heart drug using a so-called skinny label, a case with ramifications for the drug industry that could shape patent disputes more broadly and other legal areas. Here's what to watch for.

  • April 27, 2026

    4th Circ. Says Medicaid Fraud Convictions Lacked Evidence

    The government failed to prove the former owner of a mental health counseling company in Virginia willfully committed fraud by falsely billing Medicaid $200,000 for counseling services on two specific dates, a panel of the Fourth Circuit has found, overturning his convictions.

  • April 27, 2026

    Ropes & Gray, Cooley Lead Lilly's $2.3B Cancer Drug Buy

    Eli Lilly and Co. said Monday it will acquire privately held Ajax Therapeutics in a deal worth up to $2.3 billion, as the drugmaker looks to expand its pipeline of treatments for blood cancers.

  • April 27, 2026

    US, Indian Firms Guide $11.75B Sun Pharma-Organon Deal

    Indian pharmaceutical giant Sun Pharmaceutical Industries Ltd. has agreed to acquire New Jersey-based Organon & Co. in an all-cash deal valued at $11.75 billion, with each side of the transaction having representation from one U.S. and one Indian law firm.

  • April 24, 2026

    Disability Groups Back Psilocybin Home Access In Ore.

    The Oregon Health Authority's refusal to allow home-based psilocybin services for terminally ill patients who cannot travel violates federal law, a coalition of disability rights groups have told an Oregon federal court in a brief in favor of broadening the state's psilocybin access program.

Expert Analysis

  • The Role Of Operational Data In Tech Platform Liability Suits

    Author Photo

    As litigation becomes a de facto substitute for the regulation of major technology platforms, with plaintiffs advancing claims under product liability, public nuisance and consumer protection laws, among others, courts are evaluating how platform systems operate in practice based on large-scale operational data, say attorneys at Brattle.

  • 2 Discovery Rulings Break With Heppner On AI Privilege Issue

    Author Photo

    While a New York federal court’s recent ruling in U.S. v. Heppner suggests that some litigants’ communications with AI tools are discoverable, two other recent federal court decisions demonstrate that such interactions generally qualify for work-product protection under the Federal Rules of Civil Procedure, says Joshua Dunn at Brown Rudnick.

  • Bid Protest Spotlight: Evidence, Tailored Talks, Materiality

    Author Photo

    In this month's bid protest roundup, Brian Doll at MoFo delves into three recent decisions from the Government Accountability Office about the evidentiary standards necessary to sustain a protest, discussions tailored to individual proposals, and misrepresentation claims involving factors irrelevant to the agency's decision.

  • Series

    Isshin-Ryu Karate Makes Me A Better Lawyer

    Author Photo

    My involvement in martial arts, specifically Isshin-ryu, which has principles rooted in the eight codes of karate, has been one of the most foundational in the development of my personality, and particularly my approach to challenges — including in my practice of law, says Kaitlyn Stone at Barnes & Thornburg.

  • Class Actions At The Circuit Courts: April Lessons

    Author Photo

    In this month's review of class action appeals, Mitchell Engel at Shook Hardy identifies practice tips from three recent rulings involving allegations of racial discrimination in mortgage applications, health insurance networks and actual cash value losses.

  • Fraud Enforcement, Sentencing Face Unusual Convergence

    Author Photo

    The Trump administration’s newly created task force to eliminate fraud and the U.S. Sentencing Commission’s recent proposals to scale back certain elements of the federal sentencing framework seem to point in opposite directions, creating a collision of policy priorities that may reshape how fraud cases are charged, negotiated and sentenced for years to come, says David Tarras at Tarras Defense.

  • Peptide Policy Is Shifting Toward Sanctioned Compounding

    Author Photo

    The policy landscape for peptides is undergoing a significant shift under the Trump administration, moving toward a complex system of verified compounding and complementary enforcement that will likely bring peptides firmly back into the sphere of legitimate consumer products, say attorneys at Sheppard.

  • Keys To Building Defensible Psychedelic Therapy Programs

    Author Photo

    Given the rapidly evolving legal environment for psychedelic therapies and heightened liability and compliance risks facing providers, meticulous documentation, robust risk management protocols, and proactive engagement with professional organizations and insurers are essential strategies, say Kimberly Chew at Husch Blackwell and L. Alison McInnes at Mindful Health Solutions.

  • Opinion

    State Bars Need To Get Specific About AI Confidentiality

    Author Photo

    Lawyers need to put actual client information into artificial intelligence tools to get their full value, but they cannot confidently do so until state bars offer clear, formal authority on which plan tiers of the three most popular generative AI tools are safe to use when sharing specific client details, says attorney Nick Berk.

  • Trump Order Signals Tougher Benefits Fraud Probes

    Author Photo

    A recent order from President Donald Trump establishing a federal taskforce for addressing fraud in federally funded benefit programs emphasizes interagency information sharing, potentially affecting a broad range of areas including government contracts, administrative law considerations and False Claims Act cases, say attorneys at Morgan Lewis.

  • Opinion

    Judicial Restraint Anchors Constitutional Order

    Author Photo

    Contrasting opinions in two recent U.S. Supreme Court rulings — Trump v. CASA and Bost v. Illinois State Board of Elections — demonstrate how the judiciary’s constitutionally entrusted role can easily be preserved or disrupted, and invite renewed attention to the enduring importance of judicial restraint, says Ninth Circuit Judge J. Clifford Wallace.

  • The Evolution Of States' Workplace Violence Prevention Laws

    Author Photo

    Utah's new law requiring hospitals to implement comprehensive workplace violence reporting systems continues a broader trend of state efforts to expand workplace protections in the absence of sufficient federal regulations, say attorneys at Ogletree.

  • Series

    Alpine Skiing Makes Me A Better Lawyer

    Author Photo

    Skiing has shaped habits I rely on daily as an attorney — focus, resilience and the ability to remain steady when circumstances shift rapidly — and influences the way I approach legal strategy, client counseling and teamwork, says Isaku Begert at Marshall Gerstein.

  • Weighing The Practical Implications Of SC Kids' Privacy Law

    Author Photo

    South Carolina's recently enacted Age-Appropriate Code Design Act includes a unique provision: a private right of action for certain violations, but its practical effect remains uncertain, as courts and litigants grapple with complex questions of standing, causation and the definition of actionable harm, say attorneys at K&L Gates.

  • FDA Guidance May Move Goalposts For Form 483 Responses

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration provides formal insight on how drug manufacturers are expected to respond to Form 483s, raising some concerns about the agency's timelines and expectations, say attorneys at Cooley.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.